Neovascularization, Pathologic
Neovascularization, Pathologic
Explore linked clinical trials. Standard reference: MESH:M001462034 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, age-related macular degeneration, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder, wet macular degeneration | Recruiting | Phase 2 / Phase 3 | 2026-10-02 | NCT07440225 | |
| Speculum-Free Intravitreal Injection Using Cotton-Tipped Applicator Retraction: Pain, Procedure Time, Patient Satisfaction, and Safety | Embolism and Thrombosis, Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Polypoidal Choroidal Vasculopathy, Venous Thrombosis, cardiovascular disorder, choroidal neovascularization, diabetic macular edema, eye disorder, optic choroid disorder, retinal disorder, retinal vein occlusion, thrombotic disease, uveal disorder, vascular disorder | Active, not recruiting | Not applicable | 2026-09-25 | NCT07481500 | |
| Corneal Crosslinking for Treatment of Corneal Neovascularization | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, corneal disorder, corneal neovascularization, eye disorder | Recruiting | Phase 2 / Phase 3 | 2026-09-17 | NCT04787471 | |
| A Study to Evaluate the Efficacy and Safety of VIS-101 in Participants With Neovascular Age-Related Macular Degeneration | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder | Not yet recruiting | Phase 2 | 2026-09-10 | NCT07798375 | |
| NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration | Eye Diseases, Hereditary, Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, age-related macular degeneration, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder, wet macular degeneration | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-10 | NCT05984927 | |
| A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, age-related macular degeneration, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder, wet macular degeneration | Recruiting | Phase 2 / Phase 3 | 2026-08-06 | NCT07496567 | |
| Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD | Eye Diseases, Hereditary, Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, age-related macular degeneration, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder, wet macular degeneration | Active, not recruiting | Phase 3 | 2026-08-03 | NCT05407636 | |
| Biomarkers and Choroidal Neovascularization | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, adrenal gland disorder, adrenal gland hyperfunction, central serous chorioretinopathy, choroidal neovascularization, endocrine system disorder, eye disorder, hyperaldosteronism, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder | Recruiting | Not stated | 2026-07-07 | NCT04439708 | |
| AVIGA3 (Cohort 2.0) | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder | Recruiting | Not applicable | 2026-06-24 | NCT07255859 | |
| Fine-needle Diathermy Combined With Subconjunctival Bevacizumab for Corneal Neovascularization | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, corneal disorder, corneal neovascularization, eye disorder | Recruiting | Not applicable | 2026-06-11 | NCT07642960 | |
| Urethral Vascularization and Urodynamics | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, Male Urogenital Diseases, Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urinary Incontinence, Urinary Incontinence, Stress, Urination Disorders, Urogenital Diseases, Urological Manifestations, urinary system disorder | Enrolling by invitation | Not applicable | 2026-05-19 | NCT07185698 | |
| Early Vitrectomy vs PRP in Early Proliferative Diabetic Retinopathy | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Retinal Neovascularization, eye disorder, retinal disorder | Recruiting | Not applicable | 2026-05-14 | NCT07586787 | |
| Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD | Eye Diseases, Hereditary, Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, age-related macular degeneration, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder, wet macular degeneration | Active, not recruiting | Phase 2 / Phase 3 | 2026-04-28 | NCT04704921 | |
| Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Polypoidal Choroidal Vasculopathy, age-related macular degeneration, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder | Recruiting | Phase 3 | 2026-03-10 | NCT07461441 | |
| Theravex Oral and Theravex Tissue Care Plus in the Healing Process of Mucogingival Surgery | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Periodontal Atrophy, Stomatognathic Diseases, gingival disorder, gingival recession, mouth disorder, periodontal disorder | Recruiting | Not applicable | 2026-02-24 | NCT07430670 | |
| Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT] | Eye Diseases, Hereditary, Metaplasia, Neovascularization, Pathologic, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, blindness (disorder), choroidal neovascularization, eye disorder, macular degeneration, nervous system disorder, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder, vision disorder, wet macular degeneration | Active, not recruiting | Not stated | 2026-02-10 | NCT04645212 | |
| Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Vasculopathy (MONDEGO) | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Polypoidal Choroidal Vasculopathy, choroidal neovascularization, eye disorder, optic choroid disorder, uveal disorder | Recruiting | Phase 4 | 2026-02-06 | NCT06709339 | |
| Prospective Trial of the Efficacy and Safety of a Personalized Regimen of High-dose Aflibercept 8mg on Treatment-naive Polypoidal Choroidal Vasculopathy: the PALLAS Trial | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Polypoidal Choroidal Vasculopathy, choroidal neovascularization, eye disorder, optic choroid disorder, uveal disorder | Recruiting | Phase 3 | 2026-02-05 | NCT07389980 | |
| A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients With Polypoidal Choroidal Vasculopathy (PCV) | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Polypoidal Choroidal Vasculopathy, choroidal neovascularization, eye disorder, optic choroid disorder, uveal disorder | Not yet recruiting | Phase 4 | 2026-01-26 | NCT07365371 | |
| Dynamic 82-Rb Positron Emission Tomography (PET) for the Grading of KIDney Carcinoma | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Metaplasia, Neoplasms by Histologic Type, Neoplasms by Site, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, urinary system disorder | Not yet recruiting | Phase 2 | 2026-01-16 | NCT07346404 | |
| Clinical Study of Intrastromal Anti-VEGF Injection for Corneal Neovascularization. | DNA Virus Infections, Herpesviridae infectious disease, Infections, Keratitis, Herpetic, Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, corneal disorder, corneal neovascularization, eye disorder, eye infectious disorder, herpes simplex infectious disease, keratitis, viral eye infection, viral infectious disease | Recruiting | Phase 1 / Phase 2 | 2026-01-09 | NCT07329686 | |
| Impact of Non-Exudative Type 1 MNV on AMD Progression | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, age-related macular degeneration, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder | Active, not recruiting | Not stated | 2025-12-17 | NCT06125977 | |
| Faricimab Quarterly Maintenance for Neovascular Age Related Macular Degeneration | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, choroidal neovascularization, eye disorder, optic choroid disorder, uveal disorder | Recruiting | Phase 4 | 2025-10-01 | NCT06742307 | |
| Long Term Efficacy of Faricimab Using a Treat and Extend Regimen for Type 3 Macular Neovascularization | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder | Not yet recruiting | Phase 4 | 2025-09-23 | NCT07187804 | |
| Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA] | Metaplasia, Neovascularization, Pathologic, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, blindness (disorder), choroidal neovascularization, eye disorder, macular degeneration, nervous system disorder, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder, vision disorder, wet macular degeneration | Active, not recruiting | Phase 2 | 2025-08-22 | NCT05536973 |